Tejnaksh Healthcare (TEJNAKSH): Board Meeting

Board Meeting 1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the C

1 min read Tejnaksh Healthcare

Board Meeting

Board Meeting

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1, 2026, and ending on March 31, 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue, in view of the postponement of the Company's expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1, 2026, and ending on March 31, 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue, in view of the postponement of the Company's expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Tejnaksh Healthcare Ltd #TEJNAKSH #Corporate announcement

Track Indian stocks with ZTOX AI

View pricing

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Real-time Updates

Filings and alerts in WhatsApp or Telegram

Smart Filtering

Focus on news that matter most to you

Start on the free plan

Track 5 companies at no cost. Upgrade anytime.

Track up to 50 Compnies
Insider deals notifications
Volume breakout detection (Purly informational)
Start Free Now